HEADER TRANSCRIPTION 18-AUG-09 3IPS TITLE X-RAY STRUCTURE OF BENZISOXAZOLE SYNTHETIC AGONIST BOUND TO THE LXR- TITLE 2 ALPHA COMPND MOL_ID: 1; COMPND 2 MOLECULE: OXYSTEROLS RECEPTOR LXR-ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN: UNP RESIDUES 182-447; COMPND 5 SYNONYM: LIVER X RECEPTOR ALPHA, NUCLEAR ORPHAN RECEPTOR LXR-ALPHA, COMPND 6 NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 3; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 10 CHAIN: C, D; COMPND 11 FRAGMENT: STEROID RECEPTOR CO-ACTIVATOR 1: UNP RESIDUES 676-700; COMPND 12 SYNONYM: NCOA-1, STEROID RECEPTOR COACTIVATOR 1, SRC-1, RIP160, COMPND 13 PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN NY-REN-52; COMPND 14 EC: 2.3.1.48; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LXRA, NR1H3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH10-T1R; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSX29; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: SRC-1 PEPTIDE FROM MILLIQ WITH THE SEQUENCE BASED ON SOURCE 14 UNIPROT ENTRY Q15788 (NCOA1_HUMAN), RESIDUES 676-700. KEYWDS NUCLEAR RECEPTOR, LXR HOMODIMER, LXR SIGNALING, ALTERNATIVE SPLICING, KEYWDS 2 NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION KEYWDS 3 REGULATION, ACTIVATOR, ISOPEPTIDE BOND, PROTO-ONCOGENE, CHOLESTEROL, KEYWDS 4 ABCA1, HETERODIMER, RXR, LIGAND COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.FRADERA,D.VU,O.NIMZ,R.SKENE,D.HOSFIELD,R.WIJNANDS,A.J.COOKE, AUTHOR 2 A.HAUNSO,A.KING,D.J.BENNET,R.MCGUIRE,J.C.M.UITDEHAAG REVDAT 4 03-APR-24 3IPS 1 REMARK REVDAT 3 21-FEB-24 3IPS 1 REMARK SEQADV REVDAT 2 16-JUN-10 3IPS 1 JRNL REVDAT 1 02-JUN-10 3IPS 0 JRNL AUTH X.FRADERA,D.VU,O.NIMZ,R.SKENE,D.HOSFIELD,R.WYNANDS, JRNL AUTH 2 A.J.COOKE,A.HAUNSO,A.KING,D.J.BENNETT,R.MCGUIRE, JRNL AUTH 3 J.C.UITDEHAAG JRNL TITL X-RAY STRUCTURES OF THE LXRALPHA LBD IN ITS HOMODIMERIC FORM JRNL TITL 2 AND IMPLICATIONS FOR HETERODIMER SIGNALING. JRNL REF J.MOL.BIOL. V. 399 120 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20382159 JRNL DOI 10.1016/J.JMB.2010.04.005 REMARK 2 REMARK 2 RESOLUTION. 2.26 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 31554 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.258 REMARK 3 R VALUE (WORKING SET) : 0.255 REMARK 3 FREE R VALUE : 0.315 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1682 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.26 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.32 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2085 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.53 REMARK 3 BIN R VALUE (WORKING SET) : 0.3430 REMARK 3 BIN FREE R VALUE SET COUNT : 123 REMARK 3 BIN FREE R VALUE : 0.4120 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3931 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 18 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.69000 REMARK 3 B22 (A**2) : 0.69000 REMARK 3 B33 (A**2) : -1.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.302 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.260 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.246 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.234 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.893 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4105 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2817 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5555 ; 1.412 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6845 ; 0.921 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 476 ; 5.444 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 205 ;37.389 ;23.756 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 734 ;18.455 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;17.909 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 618 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4428 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 830 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1022 ; 0.209 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2878 ; 0.186 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1948 ; 0.186 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2152 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 77 ; 0.141 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 11 ; 0.138 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 39 ; 0.304 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.262 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3147 ; 0.912 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 944 ; 0.114 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3907 ; 1.015 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1938 ; 1.457 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1646 ; 2.224 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3IPS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-09. REMARK 100 THE DEPOSITION ID IS D_1000054712. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9330 REMARK 200 MONOCHROMATOR : DIAMOND (111), GE(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33516 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.260 REMARK 200 RESOLUTION RANGE LOW (A) : 91.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: IN-HOUSE LXR-ALPHA COMPLEX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG MME 2000, 100MM (NH4)2SO4, REMARK 280 35MM TRIS-HCL PH 7.8, 65MM IMIDAZOLE, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 61.52550 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 61.52550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 61.52550 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 61.52550 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 61.52550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 61.52550 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 61.52550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 61.52550 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS A DIMER AS REPRESENTED BY THE ASYMMETRIC REMARK 300 UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 165 REMARK 465 LYS A 166 REMARK 465 HIS A 167 REMARK 465 GLN A 168 REMARK 465 HIS A 169 REMARK 465 GLN A 170 REMARK 465 HIS A 171 REMARK 465 GLN A 172 REMARK 465 HIS A 173 REMARK 465 GLN A 174 REMARK 465 HIS A 175 REMARK 465 GLN A 176 REMARK 465 HIS A 177 REMARK 465 GLN A 178 REMARK 465 GLN A 179 REMARK 465 PRO A 180 REMARK 465 LEU A 181 REMARK 465 GLN A 182 REMARK 465 GLU A 183 REMARK 465 GLU A 184 REMARK 465 GLU A 185 REMARK 465 GLN A 186 REMARK 465 ALA A 187 REMARK 465 HIS A 188 REMARK 465 ALA A 189 REMARK 465 THR A 190 REMARK 465 SER A 191 REMARK 465 LEU A 192 REMARK 465 PRO A 193 REMARK 465 PRO A 194 REMARK 465 ARG A 195 REMARK 465 ALA A 196 REMARK 465 SER A 197 REMARK 465 SER A 198 REMARK 465 PRO A 199 REMARK 465 PRO A 200 REMARK 465 GLN A 201 REMARK 465 ILE A 202 REMARK 465 LEU A 203 REMARK 465 PRO A 204 REMARK 465 GLN A 223 REMARK 465 CYS A 224 REMARK 465 ASN A 225 REMARK 465 ARG A 226 REMARK 465 ARG A 227 REMARK 465 SER A 228 REMARK 465 PHE A 229 REMARK 465 SER A 230 REMARK 465 ASP A 231 REMARK 465 ARG A 232 REMARK 465 LEU A 233 REMARK 465 ARG A 234 REMARK 465 MET A 240 REMARK 465 ALA A 241 REMARK 465 PRO A 242 REMARK 465 ASP A 243 REMARK 465 PRO A 244 REMARK 465 HIS A 245 REMARK 465 GLU A 447 REMARK 465 MET B 165 REMARK 465 LYS B 166 REMARK 465 HIS B 167 REMARK 465 GLN B 168 REMARK 465 HIS B 169 REMARK 465 GLN B 170 REMARK 465 HIS B 171 REMARK 465 GLN B 172 REMARK 465 HIS B 173 REMARK 465 GLN B 174 REMARK 465 HIS B 175 REMARK 465 GLN B 176 REMARK 465 HIS B 177 REMARK 465 GLN B 178 REMARK 465 GLN B 179 REMARK 465 PRO B 180 REMARK 465 LEU B 181 REMARK 465 GLN B 182 REMARK 465 GLU B 183 REMARK 465 GLU B 184 REMARK 465 GLU B 185 REMARK 465 GLN B 186 REMARK 465 ALA B 187 REMARK 465 HIS B 188 REMARK 465 ALA B 189 REMARK 465 THR B 190 REMARK 465 SER B 191 REMARK 465 LEU B 192 REMARK 465 PRO B 193 REMARK 465 PRO B 194 REMARK 465 ARG B 195 REMARK 465 ALA B 196 REMARK 465 SER B 197 REMARK 465 SER B 198 REMARK 465 PRO B 199 REMARK 465 PRO B 200 REMARK 465 GLN B 201 REMARK 465 ILE B 202 REMARK 465 LEU B 203 REMARK 465 PRO B 204 REMARK 465 GLN B 223 REMARK 465 CYS B 224 REMARK 465 ASN B 225 REMARK 465 ARG B 226 REMARK 465 ARG B 227 REMARK 465 SER B 228 REMARK 465 PHE B 229 REMARK 465 SER B 230 REMARK 465 ASP B 231 REMARK 465 ARG B 232 REMARK 465 MET B 240 REMARK 465 ALA B 241 REMARK 465 PRO B 242 REMARK 465 ASP B 243 REMARK 465 PRO B 244 REMARK 465 HIS B 245 REMARK 465 GLU B 447 REMARK 465 CYS C 675 REMARK 465 PRO C 676 REMARK 465 SER C 677 REMARK 465 SER C 678 REMARK 465 HIS C 679 REMARK 465 SER C 680 REMARK 465 GLY C 696 REMARK 465 SER C 697 REMARK 465 PRO C 698 REMARK 465 SER C 699 REMARK 465 CYS D 675 REMARK 465 PRO D 676 REMARK 465 SER D 677 REMARK 465 SER D 678 REMARK 465 HIS D 679 REMARK 465 SER D 680 REMARK 465 GLY D 696 REMARK 465 SER D 697 REMARK 465 PRO D 698 REMARK 465 SER D 699 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS B 317 CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS B 317 CB - CA - C ANGL. DEV. = -19.5 DEGREES REMARK 500 LYS B 317 N - CA - CB ANGL. DEV. = -11.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 316 -7.74 64.73 REMARK 500 LYS A 317 60.24 70.10 REMARK 500 ASP A 318 -84.29 -161.48 REMARK 500 GLN A 431 23.38 -73.63 REMARK 500 ASP A 432 46.25 30.62 REMARK 500 LEU B 316 12.16 53.87 REMARK 500 LYS B 317 59.50 39.66 REMARK 500 ASP B 318 -70.72 -168.28 REMARK 500 PHE B 365 49.41 -85.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE O90 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE O90 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3IPQ RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF GW3965 SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA REMARK 900 RELATED ID: 3IPU RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF BENZISOXAZOLE UREA SYNTHETIC AGONIST BOUND TO REMARK 900 THE LXR-ALPHA DBREF 3IPS A 182 447 UNP Q13133 NR1H3_HUMAN 182 447 DBREF 3IPS B 182 447 UNP Q13133 NR1H3_HUMAN 182 447 DBREF 3IPS C 675 699 UNP Q15788 NCOA1_HUMAN 676 700 DBREF 3IPS D 675 699 UNP Q15788 NCOA1_HUMAN 676 700 SEQADV 3IPS MET A 165 UNP Q13133 EXPRESSION TAG SEQADV 3IPS LYS A 166 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS A 167 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN A 168 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS A 169 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN A 170 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS A 171 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN A 172 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS A 173 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN A 174 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS A 175 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN A 176 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS A 177 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN A 178 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN A 179 UNP Q13133 EXPRESSION TAG SEQADV 3IPS PRO A 180 UNP Q13133 EXPRESSION TAG SEQADV 3IPS LEU A 181 UNP Q13133 EXPRESSION TAG SEQADV 3IPS MET B 165 UNP Q13133 EXPRESSION TAG SEQADV 3IPS LYS B 166 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS B 167 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN B 168 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS B 169 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN B 170 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS B 171 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN B 172 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS B 173 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN B 174 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS B 175 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN B 176 UNP Q13133 EXPRESSION TAG SEQADV 3IPS HIS B 177 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN B 178 UNP Q13133 EXPRESSION TAG SEQADV 3IPS GLN B 179 UNP Q13133 EXPRESSION TAG SEQADV 3IPS PRO B 180 UNP Q13133 EXPRESSION TAG SEQADV 3IPS LEU B 181 UNP Q13133 EXPRESSION TAG SEQRES 1 A 283 MET LYS HIS GLN HIS GLN HIS GLN HIS GLN HIS GLN HIS SEQRES 2 A 283 GLN GLN PRO LEU GLN GLU GLU GLU GLN ALA HIS ALA THR SEQRES 3 A 283 SER LEU PRO PRO ARG ALA SER SER PRO PRO GLN ILE LEU SEQRES 4 A 283 PRO GLN LEU SER PRO GLU GLN LEU GLY MET ILE GLU LYS SEQRES 5 A 283 LEU VAL ALA ALA GLN GLN GLN CYS ASN ARG ARG SER PHE SEQRES 6 A 283 SER ASP ARG LEU ARG VAL THR PRO TRP PRO MET ALA PRO SEQRES 7 A 283 ASP PRO HIS SER ARG GLU ALA ARG GLN GLN ARG PHE ALA SEQRES 8 A 283 HIS PHE THR GLU LEU ALA ILE VAL SER VAL GLN GLU ILE SEQRES 9 A 283 VAL ASP PHE ALA LYS GLN LEU PRO GLY PHE LEU GLN LEU SEQRES 10 A 283 SER ARG GLU ASP GLN ILE ALA LEU LEU LYS THR SER ALA SEQRES 11 A 283 ILE GLU VAL MET LEU LEU GLU THR SER ARG ARG TYR ASN SEQRES 12 A 283 PRO GLY SER GLU SER ILE THR PHE LEU LYS ASP PHE SER SEQRES 13 A 283 TYR ASN ARG GLU ASP PHE ALA LYS ALA GLY LEU GLN VAL SEQRES 14 A 283 GLU PHE ILE ASN PRO ILE PHE GLU PHE SER ARG ALA MET SEQRES 15 A 283 ASN GLU LEU GLN LEU ASN ASP ALA GLU PHE ALA LEU LEU SEQRES 16 A 283 ILE ALA ILE SER ILE PHE SER ALA ASP ARG PRO ASN VAL SEQRES 17 A 283 GLN ASP GLN LEU GLN VAL GLU ARG LEU GLN HIS THR TYR SEQRES 18 A 283 VAL GLU ALA LEU HIS ALA TYR VAL SER ILE HIS HIS PRO SEQRES 19 A 283 HIS ASP ARG LEU MET PHE PRO ARG MET LEU MET LYS LEU SEQRES 20 A 283 VAL SER LEU ARG THR LEU SER SER VAL HIS SER GLU GLN SEQRES 21 A 283 VAL PHE ALA LEU ARG LEU GLN ASP LYS LYS LEU PRO PRO SEQRES 22 A 283 LEU LEU SER GLU ILE TRP ASP VAL HIS GLU SEQRES 1 B 283 MET LYS HIS GLN HIS GLN HIS GLN HIS GLN HIS GLN HIS SEQRES 2 B 283 GLN GLN PRO LEU GLN GLU GLU GLU GLN ALA HIS ALA THR SEQRES 3 B 283 SER LEU PRO PRO ARG ALA SER SER PRO PRO GLN ILE LEU SEQRES 4 B 283 PRO GLN LEU SER PRO GLU GLN LEU GLY MET ILE GLU LYS SEQRES 5 B 283 LEU VAL ALA ALA GLN GLN GLN CYS ASN ARG ARG SER PHE SEQRES 6 B 283 SER ASP ARG LEU ARG VAL THR PRO TRP PRO MET ALA PRO SEQRES 7 B 283 ASP PRO HIS SER ARG GLU ALA ARG GLN GLN ARG PHE ALA SEQRES 8 B 283 HIS PHE THR GLU LEU ALA ILE VAL SER VAL GLN GLU ILE SEQRES 9 B 283 VAL ASP PHE ALA LYS GLN LEU PRO GLY PHE LEU GLN LEU SEQRES 10 B 283 SER ARG GLU ASP GLN ILE ALA LEU LEU LYS THR SER ALA SEQRES 11 B 283 ILE GLU VAL MET LEU LEU GLU THR SER ARG ARG TYR ASN SEQRES 12 B 283 PRO GLY SER GLU SER ILE THR PHE LEU LYS ASP PHE SER SEQRES 13 B 283 TYR ASN ARG GLU ASP PHE ALA LYS ALA GLY LEU GLN VAL SEQRES 14 B 283 GLU PHE ILE ASN PRO ILE PHE GLU PHE SER ARG ALA MET SEQRES 15 B 283 ASN GLU LEU GLN LEU ASN ASP ALA GLU PHE ALA LEU LEU SEQRES 16 B 283 ILE ALA ILE SER ILE PHE SER ALA ASP ARG PRO ASN VAL SEQRES 17 B 283 GLN ASP GLN LEU GLN VAL GLU ARG LEU GLN HIS THR TYR SEQRES 18 B 283 VAL GLU ALA LEU HIS ALA TYR VAL SER ILE HIS HIS PRO SEQRES 19 B 283 HIS ASP ARG LEU MET PHE PRO ARG MET LEU MET LYS LEU SEQRES 20 B 283 VAL SER LEU ARG THR LEU SER SER VAL HIS SER GLU GLN SEQRES 21 B 283 VAL PHE ALA LEU ARG LEU GLN ASP LYS LYS LEU PRO PRO SEQRES 22 B 283 LEU LEU SER GLU ILE TRP ASP VAL HIS GLU SEQRES 1 C 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 2 C 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER SEQRES 1 D 25 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 2 D 25 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER HET SO4 A 2 10 HET O90 A 1 32 HET O90 B 1 32 HET SO4 D 1 10 HETNAM SO4 SULFATE ION HETNAM O90 {3-CHLORO-4-[(3-{[7-PROPYL-3-(TRIFLUOROMETHYL)-1,2- HETNAM 2 O90 BENZISOXAZOL-6-YL]OXY}PROPYL)SULFANYL]PHENYL}ACETIC HETNAM 3 O90 ACID FORMUL 5 SO4 2(O4 S 2-) FORMUL 6 O90 2(C22 H21 CL F3 N O4 S) FORMUL 9 HOH *18(H2 O) HELIX 1 1 SER A 207 GLN A 222 1 16 HELIX 2 2 SER A 246 LYS A 273 1 28 HELIX 3 3 SER A 282 ARG A 305 1 24 HELIX 4 4 ASN A 322 ALA A 329 1 8 HELIX 5 5 GLN A 332 LEU A 349 1 18 HELIX 6 6 ASN A 352 PHE A 365 1 14 HELIX 7 7 ASP A 374 HIS A 397 1 24 HELIX 8 8 LEU A 402 GLN A 431 1 30 HELIX 9 9 PRO A 436 ASP A 444 1 9 HELIX 10 10 SER B 207 GLN B 222 1 16 HELIX 11 11 SER B 246 LYS B 273 1 28 HELIX 12 12 SER B 282 ARG B 305 1 24 HELIX 13 13 LEU B 316 ASP B 318 5 3 HELIX 14 14 ASN B 322 ALA B 329 1 8 HELIX 15 15 GLN B 332 LEU B 349 1 18 HELIX 16 16 ASN B 352 PHE B 365 1 14 HELIX 17 17 ASP B 374 HIS B 397 1 24 HELIX 18 18 LEU B 402 GLN B 431 1 30 HELIX 19 19 PRO B 436 ASP B 444 1 9 HELIX 20 20 SER C 681 HIS C 686 1 6 HELIX 21 21 HIS C 686 GLU C 695 1 10 HELIX 22 22 SER D 681 HIS D 686 1 6 HELIX 23 23 HIS D 686 GLU D 695 1 10 SHEET 1 A 3 TYR A 306 ASN A 307 0 SHEET 2 A 3 SER A 312 THR A 314 -1 O SER A 312 N ASN A 307 SHEET 3 A 3 SER A 320 TYR A 321 -1 O TYR A 321 N ILE A 313 SHEET 1 B 3 TYR B 306 ASN B 307 0 SHEET 2 B 3 SER B 312 PHE B 315 -1 O SER B 312 N ASN B 307 SHEET 3 B 3 PHE B 319 TYR B 321 -1 O TYR B 321 N ILE B 313 SITE 1 AC1 3 ARG A 283 HIS C 690 GLN C 694 SITE 1 AC2 13 PHE A 257 LEU A 260 MET A 298 GLU A 301 SITE 2 AC2 13 THR A 302 ARG A 305 PHE A 315 PHE A 335 SITE 3 AC2 13 HIS A 421 GLN A 424 LEU A 428 LEU A 435 SITE 4 AC2 13 TRP A 443 SITE 1 AC3 14 PHE B 257 LEU B 260 LEU B 299 GLU B 301 SITE 2 AC3 14 THR B 302 ARG B 305 PHE B 315 LEU B 316 SITE 3 AC3 14 LEU B 331 PHE B 335 HIS B 421 LEU B 428 SITE 4 AC3 14 LEU B 435 TRP B 443 SITE 1 AC4 3 ARG B 283 HIS D 690 GLN D 694 CRYST1 123.051 123.051 91.636 90.00 90.00 90.00 P 4 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008127 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008127 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010913 0.00000